logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Changfeng Pharmaceutical (02652.HK) spent 264,400 Hong Kong dollars on repurchasing 14,500 shares on June 10th.

date
10/06/2026
Wisdom Finance and Economics APP News, Changfeng Pharmaceutical (02652.HK) announced that on June 10, 2026, it spent 264,000 Hong Kong dollars to repurchase 14,500 shares.
Latest
1 m ago
Guangxun Technology: Issuing stocks to specific individuals at a price of 167.55 yuan per share, will be listed on June 16th.
1 m ago
Publicly offered funds' investments in advanced manufacturing and tech innovation stocks have surpassed 6 trillion yuan.
2 m ago
Zhongtian Hongxin (00994.HK) recommends adopting a new share purchase plan and share incentive plan.
3 m ago
Zhongzhou Special Materials: The controlling shareholder and concerted action parties collectively reduced their holdings by 1.01%.
3 m ago
Zhonggong Education: Several directors and senior executives plan to increase their holdings by 45 to 90 million yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.